Target intelligence / Profile preview

Ubiquitin A-52 residue ribosomal protein fusion product 1 (UBA52)

Target
UBA52
Molecular classification
Other (fusion protein of ubiquitin and ribosomal protein), Ribosomal protein, Ubiquitin fusion protein
01

Overview

Ubiquitin A-52 residue ribosomal protein fusion product 1 (UBA52) is a fusion protein consisting of ubiquitin at the N terminus and ribosomal protein L40 (eL40) at the C terminus[1][2][4]. This protein is post-translationally processed to release free ubiquitin, which targets cellular proteins for degradation by the 26S proteasome, and to supply the ribosomal protein L40, a component of the large (60S) ribosomal subunit essential for protein synthesis[2][3]. UBA52 is highly conserved across eukaryotes and functions as a housekeeping gene to maintain the basal ubiquitin pool for essential cellular processes, particularly in non-stress conditions[3]. UBA52 deficiency disrupts embryogenesis, cell cycle progression, and protein synthesis, leading to developmental arrest and cell death[1][3]. There is no evidence that UBA52 is directly targeted by drugs or used as a biomarker in clinical practice. However, its fundamental role in cellular homeostasis and development makes it indispensable for organismal viability.

Other names
Ubiquitin-ribosomal protein eL40 fusion proteinUbiquitin, Large ribosomal subunit protein eL40UBCEP2rpL40RPL40CEP52HUBCEP52MGC57125MGC126879MGC126881L40Ubiquitin-52 amino acid fusion proteinUbiquitin carboxyl extension protein 52Ubiquitin-60S ribosomal protein L4060S ribosomal protein L40
02

Biological functions

Protein synthesisRibosome biogenesisCell cycle controlUbiquitin supply for protein degradationMaintenance of chromatin structureRegulation of gene expressionCellular stress response
03

Disease associations

Other (normal function is essential for embryogenesis and cell proliferation; limited evidence directly linking UBA52 to specific diseases except for reports of effect in certain developmental processes and experimental models)
04

Safety considerations

Loss of function leads to embryonic lethality, cell cycle arrest, impaired protein synthesis, and developmental arrest; essential for cell viability

Beyond the preview

Go deeper on Ubiquitin A-52 residue ribosomal protein fusion product 1 (UBA52).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin A-52 residue ribosomal protein fusion product 1 (UBA52).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call